drugset / Trial / NCT04095013
Intrathecal Bupivacaine-fentanyl and Bupivacaine-dexmedetomidine for Elective Low Segment Caesarean Section
RandomizedParallel-groupDouble-blindSupportive care
Summary
the primary objective of the study is to compare the onset and recovery times of sensory and motor blockade of the two study drugs intrathecally with low dose bupivacaine The secondary objectives of the study are to observe hemodynamics, side effects profile, and duration of postoperative analgesia
Timeline
- Start
- 2019-02-01
- Primary completion
- 2019-06-15
- Completion
- 2019-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 5 ug | Intrathecal |
| Subject | Fentanyl | Other / unclassified | 10 ug | Intrathecal |
| Background | Bupivacaine | Other / unclassified | 10 mg | Intrathecal |
Indications
No indication recorded.